Activation of PKC Isoform βI at the Blood–Brain Barrier Rapidly Decreases P-Glycoprotein Activity and Enhances Drug Delivery to the Brain
RR Rigor, BT Hawkins… - Journal of Cerebral Blood …, 2010 - journals.sagepub.com
P-glycoprotein is an ATP (adenosine triphosphate)-driven drug efflux transporter that is
highly expressed at the blood–brain barrier (BBB) and is a major obstacle to the …
highly expressed at the blood–brain barrier (BBB) and is a major obstacle to the …
[HTML][HTML] Activation of PKC isoform βI at the blood–brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain
RR Rigor, BT Hawkins, DS Miller - Journal of Cerebral Blood Flow …, 2010 - ncbi.nlm.nih.gov
P-glycoprotein is an ATP (adenosine triphosphate)-driven drug efflux transporter that is
highly expressed at the blood–brain barrier (BBB) and is a major obstacle to the …
highly expressed at the blood–brain barrier (BBB) and is a major obstacle to the …
[引用][C] Activation of PKC isoform β1 at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain
RR RIGOR, BT HAWKINS… - Journal of cerebral blood …, 2010 - pascal-francis.inist.fr
Activation of PKC isoform β1 at the blood-brain barrier rapidly decreases P-glycoprotein
activity and enhances drug delivery to the brain CNRS Inist Pascal-Francis CNRS Pascal …
activity and enhances drug delivery to the brain CNRS Inist Pascal-Francis CNRS Pascal …
Activation of PKC isoform beta (I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain.
RR Rigor, BT Hawkins, DS Miller - Journal of Cerebral Blood Flow …, 2010 - europepmc.org
P-glycoprotein is an ATP (adenosine triphosphate)-driven drug efflux transporter that is
highly expressed at the blood–brain barrier (BBB) and is a major obstacle to the …
highly expressed at the blood–brain barrier (BBB) and is a major obstacle to the …
Activation of PKC isoform beta (I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain
RR Rigor, BT Hawkins… - Journal of cerebral …, 2010 - pubmed.ncbi.nlm.nih.gov
P-glycoprotein is an ATP (adenosine triphosphate)-driven drug efflux transporter that is
highly expressed at the blood-brain barrier (BBB) and is a major obstacle to the …
highly expressed at the blood-brain barrier (BBB) and is a major obstacle to the …
[PDF][PDF] Activation of PKC isoform bI at the blood–brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain
RR Rigor, BT Hawkins, DS Miller - Journal of Cerebral Blood Flow & …, 2010 - academia.edu
P-glycoprotein at the blood–brain barrier (BBB) is a major obstacle to central nervous
system (CNS) pharmacotherapy (Miller et al, 2008). This ATP (adenosine triphosphate) …
system (CNS) pharmacotherapy (Miller et al, 2008). This ATP (adenosine triphosphate) …
Activation of PKC Isoform βI at the Blood–Brain Barrier Rapidly Decreases P-Glycoprotein Activity and Enhances Drug Delivery to the Brain
RR Rigor, BT Hawkins, DS Miller - Journal of Cerebral Blood Flow & …, 2010 - cir.nii.ac.jp
抄録< jats: p> P-glycoprotein is an ATP (adenosine triphosphate)-driven drug efflux
transporter that is highly expressed at the blood–brain barrier (BBB) and is a major obstacle …
transporter that is highly expressed at the blood–brain barrier (BBB) and is a major obstacle …
Activation of PKC isoform βI at the blood–brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain.
RR Rigor, BT Hawkins… - Journal of Cerebral Blood …, 2010 - search.ebscohost.com
P-glycoprotein is an ATP (adenosine triphosphate)-driven drug efflux transporter that is
highly expressed at the blood–brain barrier (BBB) and is a major obstacle to the …
highly expressed at the blood–brain barrier (BBB) and is a major obstacle to the …
[PDF][PDF] Activation of PKC isoform bI at the blood–brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain
RR Rigor, BT Hawkins, DS Miller - Journal of Cerebral Blood Flow …, 2010 - researchgate.net
P-glycoprotein at the blood–brain barrier (BBB) is a major obstacle to central nervous
system (CNS) pharmacotherapy (Miller et al, 2008). This ATP (adenosine triphosphate) …
system (CNS) pharmacotherapy (Miller et al, 2008). This ATP (adenosine triphosphate) …
Activation of PKC isoform beta (I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain.
RR Rigor, BT Hawkins, DS Miller - Journal of Cerebral Blood Flow …, 2010 - europepmc.org
P-glycoprotein is an ATP (adenosine triphosphate)-driven drug efflux transporter that is
highly expressed at the blood–brain barrier (BBB) and is a major obstacle to the …
highly expressed at the blood–brain barrier (BBB) and is a major obstacle to the …